Literature DB >> 20805493

Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.

Alina Baum1, Ravi Sachidanandam, Adolfo García-Sastre.   

Abstract

Intracellular detection of virus infections is a critical component of innate immunity carried out by molecules known as pathogen recognition receptors (PRRs). Activation of PRRs by their respective pathogen-associated molecular patterns (PAMPs) leads to production of proinflamatory cytokines, including type I IFN, and the establishment of an antiviral state in the host. Out of all PRRs found to date, retinoic acid inducible gene I (RIG-I) has been shown to play a key role in recognition of RNA viruses. On the basis of in vitro and transfection studies, 5'ppp RNA produced during virus replication is thought to bind and activate this important sensor. However, the nature of RNA molecules that interact with endogenous RIG-I during the course of viral infection has not been determined. In this work we use next-generation RNA sequencing to show that RIG-I preferentially associates with shorter, 5'ppp containing viral RNA molecules in infected cells. We found that during Sendai infection RIG-I specifically bound the genome of the defective interfering (DI) particle and did not bind the full-length virus genome or any other viral RNAs. In influenza-infected cells RIG-I preferentially associated with shorter genomic segments as well as subgenomic DI particles. Our analysis for the first time identifies RIG-I PAMPs under natural infection conditions and implies that full-length genomes of single segmented RNA virus families are not bound by RIG-I during infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805493      PMCID: PMC2941304          DOI: 10.1073/pnas.1005077107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Sendai virus defective-interfering genomes and the activation of interferon-beta.

Authors:  Laura Strahle; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

2.  Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner.

Authors:  Jesper Melchjorsen; Søren B Jensen; Lene Malmgaard; Simon B Rasmussen; Friedemann Weber; Andrew G Bowie; Sampsa Matikainen; Søren R Paludan
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells.

Authors:  Joao Trindade Marques; Thalie Devosse; Die Wang; Maryam Zamanian-Daryoush; Paul Serbinowski; Rune Hartmann; Takashi Fujita; Mark A Behlke; Bryan R G Williams
Journal:  Nat Biotechnol       Date:  2006-04-30       Impact factor: 54.908

4.  5'-Triphosphate RNA is the ligand for RIG-I.

Authors:  Veit Hornung; Jana Ellegast; Sarah Kim; Krzysztof Brzózka; Andreas Jung; Hiroki Kato; Hendrik Poeck; Shizuo Akira; Karl-Klaus Conzelmann; Martin Schlee; Stefan Endres; Gunther Hartmann
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

5.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

6.  Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.

Authors:  Takeshi Saito; Reiko Hirai; Yueh-Ming Loo; David Owen; Cynthia L Johnson; Sangita C Sinha; Shizuo Akira; Takashi Fujita; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

7.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

8.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

9.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

10.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.

Authors:  Leonid Gitlin; Winfried Barchet; Susan Gilfillan; Marina Cella; Bruce Beutler; Richard A Flavell; Michael S Diamond; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-19       Impact factor: 11.205

View more
  239 in total

1.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.

Authors:  Alys Peisley; Cecilie Lin; Bin Wu; McGhee Orme-Johnson; Mengyuan Liu; Thomas Walz; Sun Hur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome.

Authors:  Jennifer German Shipley; Rianna Vandergaast; Lu Deng; Roy A Mariuzza; Brenda L Fredericksen
Journal:  Virology       Date:  2012-07-07       Impact factor: 3.616

4.  Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.

Authors:  Maria Teresa Sánchez-Aparicio; Dominique Garcin; Charles M Rice; Daniel Kolakofsky; Adolfo García-Sastre; Alina Baum
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

5.  Differential recognition of viral RNA by RIG-I.

Authors:  Alina Baum; Adolfo García-Sastre
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

6.  Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.

Authors:  GuanQun Liu; Yao Lu; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

7.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

8.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

9.  Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Authors:  Xiomara Mercado-López; Christopher R Cotter; Won-Keun Kim; Yan Sun; Luis Muñoz; Karla Tapia; Carolina B López
Journal:  Vaccine       Date:  2013-10-05       Impact factor: 3.641

10.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.